← Leaderboards
Chun Geun Lee
Yale University
$5,468,680
Attributed
$5,468,680
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $763K · FY2007–24$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,468,680 · 3
By mechanism
R01$5,468,680 · 3
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Jack A Elias$29,308,180
- Mary E. Choi$7,200,453
- Paul Wesley Noble$36,197,130
- Lauren E Cohn$6,596,720
- Zhou Zhu$4,616,353
Others in their field
Top investigators on “Evaluation”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- David Heimbrook · Leidos Biomedical Research, Inc.$564,050,020
- Lawrence Corey · Fred Hutchinson Cancer Center$559,122,174
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$489,869,793
- Jeffrey P Krischer · University Of South Florida$466,087,841
- Judith S. Currier · University Of California Los Angeles$403,175,569
Research focus
EvaluationInflammationMyofibroblastPathogenesisResponseLungProteinsFibrosisPulmonary FibrosisTissuesSignal TransductionChronic Obstructive Airway DiseaseTransforming Growth FactorsApoptosisTransgenic OrganismsGenerationsEpithelial CellsAnimal ModelProductionTransforming Growth Factor BetaLifeIn VivoInterstitial Lung DiseasesLung Diseases
Grant awards (14)
Chitinase1 Regulation of Pulmonary Fibrosis and Therapeutic Targeting$398,750
R01 · FY2024 · HL · contact PI
Chitinase1 Regulation of Pulmonary Fibrosis and Therapeutic Targeting$398,750
R01 · FY2023 · HL · contact PI
Chitinase1 Regulation of Pulmonary Fibrosis and Therapeutic Targeting$398,750
R01 · FY2022 · HL · contact PI
Chitinase1 Regulation of Pulmonary Fibrosis and Therapeutic Targeting$397,500
R01 · FY2021 · HL · contact PI
Chitinase1 as a Biomarker and Therapeutic Target in Scleroderma Lung Disease$355,941
R01 · FY2017 · HL · contact PI
Chitinase1 as a Biomarker and Therapeutic Target in Scleroderma Lung Disease$358,644
R01 · FY2016 · HL · contact PI
Chitinase1 as a Biomarker and Therapeutic Target in Scleroderma Lung Disease$360,409
R01 · FY2015 · HL · contact PI
Chitinase1 as a Biomarker and Therapeutic Target in Scleroderma Lung Disease$383,908
R01 · FY2014 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$413,750
R01 · FY2011 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$413,750
R01 · FY2010 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$413,750
R01 · FY2009 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$349,258
R01 · FY2009 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$413,020
R01 · FY2008 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$412,500
R01 · FY2007 · HL · contact PI